About Worldwide  |     FAQs    |    Careers    |        Media Center  |    Taj Pharmaceuticals  World   |    TAJ Group
 

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
HOME PAGE

 
 >> About us
 >> History
 >> Strategy
 >> Products evolution Timeline
 >> Sectors & Markets
 >> Products
 >> Innovation
 >> Sustainable Development 
 >> Image gallery
 >> Worldwide presence
 


 

   Business Opportunities

   
API Development and Production
Dosage Form Development and Manufacturing
Contract Manufacturing
Sales and Marketing
Marketing Strategies
Licensing
   

 

 		  


Healthcare for people. As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.

Vision
To be a globally admired Pharma company for world-class quality and innovation


Mission

Rs.100 crore (US$25m) company by 2019-11 (domestic & international organic growth)

Amongst Top 30 Pharma companies(domestic) by 2012-13 (organic + inorganic growth)

Setup full-fledged R&D and API Unit by 2019

Business across all continents by 2013-14

Custom Peptide Synthesis
At its peptide facility in Mumbai, India, USV has a team of scientists using solid and solution phase chemistry employing Fmoc and t-Boc methodologies for the design and production of peptides for research more >>>
Branded Generics

Finished Dosages are marketed globally, through two independent business units, one focused on India and the other, on international markets....
more >>>		 Generics

Generics for North America being targeted with ANDA's and commercialized through Indicus Pharma LLC. We also market Generics in the EU…....
more >>>

APIs
We are the largest manufacturer of generic metformin in the world. Our portfolio includes 17 molecules, which are marketed globally including USA, EU and Japan.		 Biotherapeutics
Focus is on peptides and rDNA proteins backed by validated bio-assays. Eptifibatide and hGH (through non-infringing methods)
on offer......
more >>>		  


 

July 28, 2008

Taj Life Sciences launches Omeprazole 40 mg capsules

June 25, 2008

Taj Life Sciences gains tentative approval to manufacture and market Valganciclovir Hydrochloride tablets

June 18, 2008

Taj Life Sciences and

Read more >>





















 
      Investor Relations    Feedback     Contact Worldwide    Sitemap
 

Copyright © 2008 Taj Life Sciences Pvt.Ltd. (ताज लाइफ साइंसेज प्राइवेट लिमिटेड) All rights reserved. This site is best viewed in 1024 X 768
This website is intended for people seeking information on the Taj Life Sciences Pvt.Ltd bWorldwideiness. If you are in the Worldwide you should visit Taj Group Worldwide.
We also have national World wide Business sites which can be found under our list of Taj Group websites. (ताज ग्रुप)
We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact Worldwide.